RXST PEER ANALYSIS

Rxsight Inc — metric-by-metric comparison with peers and the industry median

RXSTRxsight Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

RXSTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	RXST	SN	ONCSM	MEDTR	ANGEN	4DX	Ind. Median
P/E	—	20.73●	122.41	596.83	—	—	26.82
P/B	0.87	2.50	13.36	1.08	1.32	-76.08●	2.50
EV/EBITDA	—	9.94●	25.46	10.93	34.77	—	15.54
P/S	1.81	2.10	7.66	1.18●	2.95	249.46	2.69

Financial Health
Metric	RXST	SN	ONCSM	MEDTR	ANGEN	4DX	Ind. Median
Current Ratio	10.20●	2.57	2.25	3.58	2.31	6.57	3.28
Debt/Equity	4.1%	62.9%	35.0%	1.0%	28.1%	-22.6%●	44.7%
NetDebt/EBITDA	4.79	1.72	0.42	-1.64●	4.71	0.71	0.82

Profitability
Metric	RXST	SN	ONCSM	MEDTR	ANGEN	4DX	Ind. Median
Net Margin	-36.6%	10.1%●	6.3%	0.2%	-45.0%	-3,684.6%	-5.7%
ROE	-17.1%	12.1%	12.9%●	0.2%	-21.0%	—	-8.6%
ROA	-15.1%	6.1%	8.0%●	0.2%	-15.7%	-264.3%	-6.4%
EBITDA Margin	-33.9%	25.6%	30.6%●	9.4%	9.8%	-818.8%	5.2%

Growth + Dividend
Metric	RXST	SN	ONCSM	MEDTR	ANGEN	4DX	Ind. Median
Rev. Growth	-19.5%	—	39.1%●	6.5%	11.7%	-26.0%	7.4%
NI Growth	—	—	—	-62.9%	—	—	16.7%
Div. Yield	—	3.5%●	0.0%	1.1%	0.0%	—	1.1%
Payout	—	52.8%	0.0%	656.3%	0.0%	—	39.0%

Valuation
Metric	RXST	INFU	QTRX	QSI	TMCI	SGHT	Ind. Median
P/E	—	26.33	—	—	—	—	26.82
P/B	0.87	3.55	0.71●	1.03	3.82	5.48	2.50
EV/EBITDA	—	8.86	—	—	—	—	15.54
P/S	1.81	1.46	1.39●	111.24	1.42	3.72	2.69

Financial Health
Metric	RXST	INFU	QTRX	QSI	TMCI	SGHT	Ind. Median
Current Ratio	10.20	2.14	3.72	12.60●	3.58	5.86	3.28
Debt/Equity	4.1%	38.8%	12.5%	1.8%●	17.6%	77.5%	44.7%
NetDebt/EBITDA	4.79	0.80	0.76●	1.35	0.83	1.36	0.82

Profitability
Metric	RXST	INFU	QTRX	QSI	TMCI	SGHT	Ind. Median
Net Margin	-36.6%	5.6%●	-71.9%	-5,605.9%	-29.4%	-46.8%	-5.7%
ROE	-17.1%	13.9%●	-34.8%	-46.4%	-66.9%	-56.6%	-8.6%
ROA	-15.1%	7.8%●	-27.3%	-42.9%	-31.3%	-31.1%	-6.4%
EBITDA Margin	-33.9%	18.2%●	-58.4%	-4,942.7%	-22.3%	-39.8%	5.2%

Growth + Dividend
Metric	RXST	INFU	QTRX	QSI	TMCI	SGHT	Ind. Median
Rev. Growth	-19.5%	3.5%	8.2%●	-46.2%	-1.7%	1.8%	7.4%
NI Growth	—	148.0%	—	—	—	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on RXST

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.